Published • loading... • Updated
Drug combination shows promise against advanced prostate cancer
Summary by Scienmag: Latest Science and Health News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Scienmag: Latest Science and Health NewsReposted by 
BIOENGINEER.ORG
BIOENGINEER.ORGDrug combination shows promise against advanced prostate cancer
A new study from researchers at the University of Michigan has identified a potential two-drug strategy for treating an aggressive form of prostate cancer that can emerge after standard hormone therapies stop working. The experimental treatment combines BET bromodomain inhibitors with DNA methyltransferase, or DNMT, inhibitors—two classes of epigenetic drugs that influence how cancer cells read and use their genetic instructions. In laboratory m…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
